Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
2007 1
2009 2
2010 3
2011 2
2012 8
2013 14
2014 4
2015 7
2016 3
2017 5
2018 4
2019 2
2020 2
2021 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk.
Fadini GP, Longato E, Morieri ML, Del Prato S, Avogaro A, Solini A; DARWIN-Renal Study Investigators. Fadini GP, et al. Lancet Reg Health Eur. 2024 Feb 1;38:100847. doi: 10.1016/j.lanepe.2024.100847. eCollection 2024 Mar. Lancet Reg Health Eur. 2024. PMID: 38328413 Free PMC article.
Letter to the Editor regarding the paper by F. Cardoso et al. 'European Breast Cancer Conference manifesto on breast centres/units'.
Saguatti G, Naldoni C, Benelli E, Fedato C, Frigerio A, Galli V, Giordano L, Golinelli P, Morrone D, Paduos A, Querci F, Rizzo A, Bucchi L. Saguatti G, et al. Among authors: querci f. Eur J Cancer. 2017 Dec;87:199-200. doi: 10.1016/j.ejca.2017.05.040. Epub 2017 Jun 26. Eur J Cancer. 2017. PMID: 28662905 No abstract available.
Exenatide versus glibenclamide in patients with diabetes.
Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Ragonesi PD, Querci F, Franzetti IG, Gadaleta G, Ciccarelli L, Piccinni MN, D'Angelo A, Cicero AF. Derosa G, et al. Among authors: querci f. Diabetes Technol Ther. 2010 Mar;12(3):233-40. doi: 10.1089/dia.2009.0141. Diabetes Technol Ther. 2010. PMID: 20151774 Clinical Trial.
Continuous subcutaneous insulin infusion in Italy: third national survey.
Bruttomesso D, Laviola L, Lepore G, Bonfanti R, Bozzetto L, Corsi A, Di Blasi V, Girelli A, Grassi G, Iafusco D, Rabbone I, Schiaffini R; Italian Study Group on Diffusion of CSII. Bruttomesso D, et al. Diabetes Technol Ther. 2015 Feb;17(2):96-104. doi: 10.1089/dia.2014.0242. Epub 2014 Dec 5. Diabetes Technol Ther. 2015. PMID: 25479035 Free article.
Enrolment criteria for diabetes cardiovascular outcome trials do not inform on generalizability to clinical practice: The case of glucagon-like peptide-1 receptor agonists.
Sciannameo V, Berchialla P, Orsi E, Lamacchia O, Morano S, Querci F, Consoli A, Avogaro A, Fadini GP; DARWIN-T2D study. Sciannameo V, et al. Among authors: querci f. Diabetes Obes Metab. 2020 May;22(5):817-827. doi: 10.1111/dom.13962. Epub 2020 Feb 6. Diabetes Obes Metab. 2020. PMID: 31943710 Free article.
54 results